T2B Biopharma Comms Forum | June 17, 2025
Theme: The Next Chapter
In-house teams, agency strategists, boutique consultants, aspiring communicators – all T2B members welcome!
Our in-person programming is about to go up a gear (or two), with our first-ever in-person Biopharma Comms Forum!
Taking place at Takeda’s 125 Binney St. location in Cambridge, MA on Tuesday, June 17th, the event’s theme is “The Next Chapter.” We’ll address the evolving environment, skills, and leadership needed for success as modern-day biopharma communicators both today and in the future.
We want this to be a two-way, interactive event: It’s not just a day full of presentations, where you sit in “receive” mode for several hours. Instead, attendees will benefit from networking, small-group discussions, keynotes, case studies, and panels with industry peers.
And to cap it all off, we’ll all gather for our BIO / Q2 Boston area meetup in the evening!
Throughout the day, we’ll focus on topics spanning:
- Real talk about gaining C-suite respect as a corporate affairs leader
- Keeping up with AI and technological shifts to maintain our profession’s relevancy
- What it means to be a modern-day biopharma communicator
- And more!
Keynote Announced!
Humanizing Biotech Communications in the Age of AI – A Discovery Session with Michal Preminger
In this candid, forward-looking conversation, Michal will dig into where comms earns its influence, where it loses it, and what it takes to stay essential in a world shaped by AI, evolving leadership, and rising expectations. She’ll reflect on moments when communications built real trust—and how speaking with honesty and a personal voice makes a far stronger connection than sticking to the script.
Until recently, Michal served as Regional Head of Johnson & Johnson Innovation, East North America. In this role, she led the J&J team in sourcing, evaluating, and executing partnerships and investment deals with the most promising early-stage healthcare innovations in the region, with the goal of advancing them into J&J’s product pipelines to benefit patients. Previously, Michal held senior leadership roles at Harvard University, overseeing technology development and strategic partnerships at Harvard Medical School. There, she initiated, negotiated, and managed numerous high-impact industry licenses and alliances, helped launch successful startups, and contributed to a cultural shift toward scientific entrepreneurship among faculty and trainees. Earlier in her career, Michal held executive roles in the biotech and tech industries, including at Compugen Ltd (NASDAQ: CGEN). During her current sabbatical, Michal remains active in the innovation ecosystem, among other by serving on the Board of Directors of MassBio and the Kendall Square Association (KSA).
Throughout her career, Michal invested extensively in both internal and external communication and branding, both as part of her formal roles and extracurricularly. Among other, she is a co-host of the #BiotechHangout on X and is followed by a large audience on social media.
Michal holds MSc and PhD degrees from the Weizmann Institute of Science and an MBA from INSEAD.
Registration open for all T2B Community Members
SIGN UP HERE for free* if you’re a T2B Pro or Student member.
REGISTER HERE if you’re a T2B Basic member (ticket price: $475, includes access to T2Bmeet @ BIO/Boston).
RSVP HERE if you ONLY want to attend T2Bmeet @ BIO/Boston on June 17th from 5-7 p.m. (ticket price: $50).
*To secure your spot, a $0.50 processing fee and valid credit card are required; your card details are encrypted and stored securely by Stripe. A $475 no-show fee will only be charged if you do not cancel at least one week before the event by emailing [email protected].
Meet our sponsors
About Our Host, Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.
About Our Marquee Sponsor, Waterhouse
Waterhouse Brands, LLC is a brand reputation agency dedicated to helping life sciences companies create Reputational Pull™ among investors, talent and industry partners. Using its time-tested ALIGN Methodology™ as a tool to articulate competitive advantage, Waterhouse fuses strategy with creative brand activations and communications programs across the full ecosystem of market awareness. Since its inception, Waterhouse has built brands and helped scale culture for some of the fastest growing companies in the industry, proving the power of authentic positioning to engage stakeholders and drive enterprise value. Waterhouse was founded in 2017 by Kimberly Kraemer, a 2025 Ragan Communications Top Women in Communications Honoree.
About Our Supporter, Fullintel
Fullintel stands at the forefront of innovation in media monitoring and intelligence, committed to providing PR and communications professionals with the tools and insights needed to navigate the complex media landscape. Our dedication to research-based solutions and best practices ensures our clients are equipped with the most advanced approaches to media measurement and analysis.
About Our Supporter, Jygantic
At Jygantic, we spark – launch – grow and scale the future of science. We create anything you can see, hear, and feel that translates complex ideas into simple, beautiful, and compelling stories. We are obsessive compulsive problem solvers – design is our love language / science is our dialect. Jygantic has been serving life science companies of every shape, stage and size since 2018. Our team of seasoned strategists, artists, scientists, producers and creative problem solvers have seen and done it all. From seed stage to the closing bell, we’re committed to doing our part to build a healthier future – by building an understanding of what you do, why it matters, and how it’s going to change the world.
What is a modern-day communicator?
This is how we’re thinking about our function’s evolution. We’ll explore all this in more depth during our forum!
A strategic thinker and business partner
No longer just a storyteller, today’s biopharma communicator is deeply embedded in corporate strategy, often overlapping with Chief of Staff or executive advisory roles. We anticipate risks, align messaging with business goals, and shape narratives that drive corporate success.
Adaptive and tech-savvy
The rapid evolution of AI, digital media, and new communication platforms means communicators need to integrate emerging tools while maintaining ethical and accurate messaging.
We must navigate misinformation, leverage data-driven insights, and optimize AI-enhanced workflows for media monitoring, stakeholder engagement, and strategic positioning.
Able to build relationships and communities
Beyond media and investor relations, the modern communicator fosters meaningful connections across the industry with key stakeholders, including internal teams, regulators, patient advocates, and journalists. We recognize that relationships – whether through informal networking, online communities, or strategic partnerships – are key to credibility and influence.
A cross-functional operator
With communication responsibilities bleeding into other disciplines, today’s biopharma comms pros often work at the intersection of corporate affairs, policy, advocacy, market access, and digital engagement. Managing, understanding, influencing, and on many occasions juggling these adjacent functions is increasingly crucial.
A creative problem-solver and innovator
While consistency in messaging is important, today’s communicators must also champion fresh ideas, experiment with new storytelling formats, and introduce new approaches that align with evolving audience behaviors and expectations.
A mentor and ecosystem builder
The new generation of communicators is shaping the next chapter of the profession. We’re not just focusing on our own career growth but also actively mentoring others, defining best practices, and fostering an inclusive, knowledge-sharing ecosystem.